In a report released yesterday, Ryan Zimmerman from BTIG maintained a Hold rating on Vicarious Surgical (RBOT – Research Report). The company’s shares opened today at $0.39.
Zimmerman covers the Healthcare sector, focusing on stocks such as Glaukos, Vericel, and Stryker. According to TipRanks, Zimmerman has an average return of 8.9% and a 47.46% success rate on recommended stocks.
Vicarious Surgical has an analyst consensus of Hold, with a price target consensus of $1.00.
See today’s best-performing stocks on TipRanks >>
RBOT market cap is currently $64.13M and has a P/E ratio of -0.70.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Vicarious Surgical (RBOT) Company Description:
D8 Holdings Corp is a blank check company.
Read More on RBOT:
- Vicarious Surgical initiated with an Equal Weight at Morgan Stanley
- Vicarious Surgical price target lowered to $1.50 from $4 at Piper Sandler
- Vicarious Surgical downgraded to Neutral from Buy at BTIG
- Vicarious Surgical downgraded to Hold from Buy at Canaccord
- Vicarious Surgical sees FY23 cash burn $60M-$65M
